Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
暂无分享,去创建一个
A. Hui | Ö. Türeci | U. Şahin | Ruiru Ji | Jing-xin Li | Xi-ling Guo | F. Zhu | H. Pan | Xiang Zhang | A. Muik | Zhenggang Wu | R. Tang | Zhilong Ma | E. Lagkadinou | Li Zhu | Huayue Ye | Mei Lin | Fuzhong Peng | Yunfeng Shi | Yumei Yang | Zhong-kui Zhu | S. Jia